TopoTarget A/S Release: Final Data From BELIEF Study for American Society of Clinical Oncology 2013 Confirms Objective Response Rate of 26%
5/16/2013 9:55:16 AM
More...
|
TopoTarget A/S Release: Shareholder Meetings in Copenhagen and Aarhus
5/14/2013 9:04:01 AM
More...
|
TopoTarget A/S Announces the Interim Report for Q4 2012
1/31/2013 9:52:26 AM
More...
|
TopoTarget A/S Announces the Time and Date for the Telephone Conference Related to the Publishing of the Interim Report for Q4 2012
1/23/2013 8:54:46 AM
More...
|
TopoTarget A/S Grants Exclusive License to Oncology Venture Regarding APO010
11/13/2012 8:08:23 AM
More...
|
Topotarget Announces the Interim Report for Q3 2012
11/12/2012 7:57:51 AM
More...
|
TopoTarget A/S Announces the Time and Date for the Telephone Conference Related to the Publishing of the Interim Report for Q3 2012
11/8/2012 9:25:45 AM
More...
|
TopoTarget A/S Release: Notice to Convene Extraordinary General Meeting
11/2/2012 7:17:53 AM
More...
|
TopoTarget A/S Release: Belinostat Gets EU Orphan Drug Designation for the Treatment of Peripheral T-cell Lymphoma
10/15/2012 9:45:35 AM
More...
|
Apricus Biosciences (APRI) Launches Commercialization Arm With Definitive Agreement to Acquire TopoTarget A/S
12/16/2011 10:31:23 AM
More...
|
|